目的：使用CiteSpace软件对黄连温胆汤应用于代谢性心血管疾病的相关研究进行可视化分析，梳理研究现状和热点，为后续研究提供思路和参考。方法：检索万方数据知识服务平台（Wanfang）、维普中文科技期刊数据库（VIP）、中国学术期刊全文数据库（CNKI）等中文文献数据库中2000年1月1日至2023年12月31日发表的与黄连温胆汤相关的文献，人工收集并筛选涉及代谢性心血管疾病的文献，使用NoteExpress合并、去重后导入CiteSpace 6.3.R1软件，对纳入文献的年发文量、作者、研究机构和关键词进行文献计量学分析，并绘制可视化图谱。结果：共检索出3781篇相关文献，最终纳入548篇有效文献；发文量整体呈上升趋势，2021年达高峰；核心作者群已初步形成，但目前团队合作网络尚未明显形成；发文量排名前两位的研究机构为黑龙江中医药大学和山东中医药大学；关键词主要集中在疾病治疗、中医病机和研究层次3个方面。结论：黄连温胆汤在治疗代谢性心血管疾病中应用广泛，胰岛素抵抗与炎症反应是导致该病的重要因素；临床疗效、作用机制研究是当前该方向的研究热点；未来研究趋势为对黄连温胆汤具体作用机制的深入发掘。

Objective： Using CiteSpace software to conduct a visual analysis of the relevant research on the application of Huanglian Wendan decoction in cardiometabolic diseases， sort out the research status and hotspots， and provide ideas and references for future research.Methods： Retrieve literature related to Huanglian Wendan decoction published from January 1， 2000 to December 31， 2023 in Chinese literature databases such as Wanfang Data Knowledge Service Platform （Wanfang）， VIP Chinese Science and Technology Journal Database （VIP）， and CNKI Chinese Academic Journal Full-text Database. Manually collect and screen literature related to cardiometabolic diseases， merge and deduplicate using NoteExpress， import into CiteSpace 6.3.R1 software， conduct bibliometric analysis on the annual publication volume， authors， research institutions， and keywords of the included literature， and draw visualization maps.Results： A total of 3781 relevant literature were retrieved out， and 548 valid literature ultimately included. The overall number of publications is on the rise， reaching the peak in 2021. The core author group has initially formed， but the team collaboration network has not yet been clearly established. The top two research institutions in terms of publication volume in this field are Heilongjiang University of Chinese Medicine and Shandong University of Traditional Chinese Medicine. The keywords mainly focus on three aspects： disease treatment， TCM pathogenesis， and research level.Conclusion： Huanglian Wendan decoction is widely used in the treatment of cardiometabolic diseases， and insulin resistance and inflammatory response are important factors leading to this disease. The research on clinical efficacy and mechanism of action is currently a hot topic in this field. The future research trend is the in-depth exploration of the specific mechanism of action of Huanglian Wendan decoction.